Clinical Trials Logo

Filter by:
NCT ID: NCT00481039 Completed - Sickle Cell Disease Clinical Trials

Sickle Cell Anemia in an Arab Bedouin Village in the Northern Israel

Start date: May 2007
Phase: N/A
Study type: Observational

Sickle cell anemia and sickle cell thalassemia are frequent diseases among the israeli arab population. The purpose of this study is to assess the clinical characteristics of the patients in one arab village and the laboratory characteristics in the carriers of this gene based in the screening for pregnant women that is carried out in the population of northern Israel. The results can be useful in order to institute universal screening for sickle cell anemia in northern Israel.

NCT ID: NCT00480974 Completed - Sickle Cell Anemia Clinical Trials

Long Term Follow up in Sickle Cell Patients Treated by Hydroxyurea

Start date: May 2007
Phase: N/A
Study type: Observational

Hydroxyurea was found to be a good treatment in adult patients with sickle cell anemia with significant decrease in the frequency of vaso-occlusive crises and other crises related to SCA. Several studies were published with relative short term follow up in pediatric and young adult age. The purpose of this study is to assess the long term follow up in a group of patients that initiated Hydroxyurea treatment in childhood.

NCT ID: NCT00480844 Recruiting - Schizophrenia Clinical Trials

Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone

Start date: October 2008
Phase: Phase 4
Study type: Interventional

In this study we intend to compare the effect of Sertindole to that of Risperidone on cognitive impairment in schizophrenia. Hypothesis: Sertindole will be as effective as Risperidone for treating cognitive impairment in schizophrenia and with fewer side effects.

NCT ID: NCT00480571 Completed - Schizophrenia Clinical Trials

Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder

Start date: June 2007
Phase: Phase 2
Study type: Interventional

An open-label, multi-center, 6-week, sequential cohort study designed to determine the safety and tolerability of two dose ranges of BL-1020 in hospitalized subjects with chronic schizophrenia or schizo-affective disorder

NCT ID: NCT00480519 Recruiting - Pain Clinical Trials

Use of Sedation and Local Anesthesia in Meatotomy: A Prospective Comparison Study

Start date: May 2007
Phase: Phase 3
Study type: Interventional

The aim of the study is to prospectively investigate the feasibility, pain control, and outcome of meatotomy performed under sedation and local anaesthesia compared with general anaesthesia with and without patient block

NCT ID: NCT00480376 Not yet recruiting - Infection Clinical Trials

Ofloxacin vs. Gentamicin as Prophylaxis Prior Transrectal Biopsy of Prostate

Start date: June 2007
Phase: Phase 4
Study type: Interventional

Prostate biopsy is usually conducted transrectal, ultrasonography guided. Since the area is not sterile, infection can be induced during the procedure. Prophylaxis antibiotic against gram-negative bacteria decreased significantly the amount of infections. Quinolones are considered preferred treatment but there is already an increase in resistance rates. TMP-SMX can not be used empirically due to a high percent of resistant uropathogens. One of the options is aminoglycosides, especially gentamicin. Advantages: very low resistance rate in the community, high concentration is urinary tract, slow clearance, no resistance developed under treatment, chip and with very few side effects.

NCT ID: NCT00480350 Not yet recruiting - HIV Infections Clinical Trials

RiSolubles™, the Soluble Fraction of Rice Bran for HIV-Infected Patients

Start date: September 2007
Phase: Phase 2
Study type: Interventional

HIV infection is a growing problem in Israel with over 4000 known patients who are either infected with the virus or have developed AIDS. Patients are usually followed for years until they develop an increase in their viral load (HIV-1 RNA) or their CD4 + cells decline. At this point, patients are usually treated with Highly Active, Anti-Retroviral Therapy (HAART). The mainstay of response to such treatment is the lowering of viral load and increase in CD4+ cells. Food supplements for HIV patients have been given in several studies, with controversial results. A meta-analysis published recently [1] assessed whether micronutrient supplements are effective in reducing morbidity and mortality in adults and children with HIV infection. They recommended supporting the current WHO recommendations to promote and support adequate dietary intake of micronutrients wherever possible. We expect to enroll 140 subjects in this randomized, double blind, placebo controlled study. Seventy subjects will be enrolled in the rice-supplement arm and 70 subjects in the control group, which will receive supplemental, flavored dextrose to their current medical treatment. The treatment duration is 24 weeks with follow-up at 36 weeks from enrollment. The target population is HIV-1 infected individuals who may be either on anti-retroviral therapy or not on therapy. Subjects must be with either CD4+ cells are <500 cells/mm3, or HIV plasma RNA level is > 5000 copies/ml. The primary objective is to demonstrate the efficacy of food supplementation versus a flavored-dextrose supplement with respect to increment of patient CD4+ cell count from baseline at 24 weeks, or virological response defined as lowering of plasma HIV-1 RNA and immunologic response.

NCT ID: NCT00480337 Completed - Clinical trials for Polycystic Ovary Syndrome

In Vitro Maturation of Immature Oocytes

Start date: n/a
Phase: N/A
Study type: Interventional

The aim of this study is to aspirate immature oocytes from antral follicles and mature the oocytes in vitro. These mature oocytes will serve for fertilization and the creation of embryos which will be replace in the uterus as performed during normal IVF.We will record the efficacy and safety of this procedure.

NCT ID: NCT00480233 Recruiting - Depression Clinical Trials

Screening Questionnaire for Depression

Start date: January 2008
Phase: N/A
Study type: Observational

Depression is common in primary care and general medical settings, but is often unrecognized and untreated by physicians working in those settings. The Patient Health Questionnaire for depression (PHQ-9) is well validated and widely used screening instrument.

NCT ID: NCT00480207 Completed - Depression Clinical Trials

Folic Acid and Omega -3 Fatty Acid Supplementation in Depressed Older Adults

Start date: May 2007
Phase: Phase 2/Phase 3
Study type: Interventional

Our specific aim is to determine the impact of folic acid and omega-3 supplementation on the severity of depressive symptoms among depressed adults aged 65 and above.